Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Crisis Rescue

NEXT STORY
Athenex to Provide Corporate and Financial Update for the Second Quarter 2021 on August 5, 2021
PREV STORY
eFFECTOR Therapeutics Doses First Patient with COVID-19 in Phase 1b Clinical Trial Evaluating Zotatifin as a Host-Targeted Antiviral Agent
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FIT Biotech Oy: First EHVA clinical trial authorization granted for testing FIT-06

FIT Biotech Oy  Company release 12.6.2018 at 8:30 AM EET First EHVA clinical trial ...

author_avatar
NASDAQ Market News

Novartis Scemblix® demonstrates sustained response rate in 48-week follow-up in patients with chronic myeloid leukemia

author_avatar
NASDAQ Market News

Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome

author_avatar
NASDAQ Market News